New-onset atrial fibrillation in sepsis is associated with increased morbidity and mortality

por Gandhi, Sumeet, Litt, Dhanjit, Narula, Neeraj
Publicado 2015

Role of endoscopy in inflammatory bowel disease

por Bharadwaj, Shishira, Narula, Neeraj, Tandon, Parul, Yaghoobi, Mohammad
Publicado 2018

Vedolizumab does not increase risk of clostridium difficile infection in patients with inflammatory bowel disease using vedolizumab: A retrospective cohort study

por Saad Alshahrani, Abdulaziz, Mohammad, Danah, attieh Alzahrani, Mohammad, Narula, Neeraj
Publicado 2023

Intake of artificial sweeteners among adults is associated with reduced odds of gastrointestinal luminal cancers: a meta-analysis of cohort and case-control studies

por Tepler, Adam, Hoffman, Gila, Jindal, Shawn, Narula, Neeraj, Shah, Shailja C.
Publicado 2021

Impact of Digital Health Monitoring in the Management of Inflammatory Bowel Disease

por Zhen, Jamie, Marshall, John K., Nguyen, Geoffrey C., Atreja, Ashish, Narula, Neeraj
Publicado 2021

Safety of Propofol versus Nonpropofol-Based Sedation in Children Undergoing Gastrointestinal Endoscopy: A Systematic Review and Meta-Analysis

por Narula, Neeraj, Masood, Sameer, Shojaee, Samira, McGuinness, Brandon, Sabeti, Saama, Buchan, Arianne
Publicado 2018

Association Between Helicobacter pylori Exposure and Decreased Odds of Eosinophilic Esophagitis—a Systematic Review and Meta-analysis

por Shah, Shailja C., Tepler, Adam, Peek, Richard M., Colombel, Jean-Frederic, Hirano, Ikuo, Narula, Neeraj
Publicado 2019

Risk for development of inflammatory bowel disease under inhibition of interleukin 17: A systematic review and meta-analysis

por Burisch, Johan, Eigner, Wolfgang, Schreiber, Stefan, Aletaha, Daniel, Weninger, Wolfgang, Trauner, Michael, Reinisch, Walter, Narula, Neeraj
Publicado 2020

The impact of ustekinumab on extraintestinal manifestations of Crohn's disease: A post hoc analysis of the UNITI studies

por Narula, Neeraj, Aruljothy, Achuthan, Wong, Emily C. L., Homenauth, Ravi, Alshahrani, Abdul‐Aziz, Marshall, John K., Reinisch, Walter
Publicado 2021

Ulcerative Colitis Patients Continue to Improve Over the First Six Months of Vedolizumab Treatment: 12-Month Clinical and Mucosal Healing Effectiveness

por Zezos, Petros, Kabakchiev, Boyko, Weizman, Adam V, Nguyen, Geoffrey C, Narula, Neeraj, Croitoru, Kenneth, Steinhart, A Hillary, Silverberg, Mark S
Publicado 2020

Impact of Adalimumab Patient Support Program’s Care Coach Calls on Clinical Outcomes in Patients with Crohn’s Disease in Canada: An Observational Retrospective Cohort Study

por Narula, Neeraj, Millson, Brad, Charland, Katia, Donepudi, Krishna, Gaetano, Tania, McHugh, Kevin, Latour, Martin G, Gazel, Sandra, Laliberté, Marie-Claude, Marshall, John K
Publicado 2018

Early life exposures and the risk of inflammatory bowel disease: Systematic review and meta-analyses

por Agrawal, Manasi, Sabino, João, Frias-Gomes, Catarina, Hillenbrand, Christen M., Soudant, Celine, Axelrad, Jordan E., Shah, Shailja C., Ribeiro-Mourão, Francisco, Lambin, Thomas, Peter, Inga, Colombel, Jean-Frederic, Narula, Neeraj, Torres, Joana
Publicado 2021

Modelling the benefits of an optimised treatment strategy for 5-ASA in mild-to-moderate ulcerative colitis

por Louis, Edouard, Paridaens, Kristine, Al Awadhi, Sameer, Begun, Jakob, Cheon, Jae Hee, Dignass, Axel U, Magro, Fernando, Márquez, Juan Ricardo, Moschen, Alexander R, Narula, Neeraj, Rydzewska, Grazyna, Freddi, Matthew J, Travis, Simon PL
Publicado 2022

The impact of clinical experience on decision-making regarding the treatment and management of mild-to-moderate ulcerative colitis

por Cheon, Jae Hee, Paridaens, Kristine, Awadhi, Sameer Al, Begun, Jakob, Fullarton, John R, Louis, Edouard, Magro, Fernando, Marquez, Juan Ricardo, Moschen, Alexander R, Narula, Neeraj, Rydzewska, Grazyna, Dignass, Axel U, Travis, Simon PL
Publicado 2023

REMIT-UC: Real-World Effectiveness and Safety of Tofacitinib for Moderate-to-Severely Active Ulcerative Colitis: A Canadian IBD Research Consortium Multicenter National Cohort Stud...

por Ma, Christopher, Panaccione, Remo, Xiao, Yasi, Khandelwal, Yuvan, Murthy, Sanjay K., Wong, Emily C.L., Narula, Neeraj, Tsai, Catherine, Peerani, Farhad, Reise-Filteau, Marica, Bressler, Brian, Starkey, Samantha Y., Loomes, Dustin, Sedano, Rocio, Jairath, Vipul, Bessissow, Talat
Publicado 2023

Correction: Vedolizumab for Ulcerative Colitis: Treatment Outcomes from the VICTORY Consortium

por Narula, Neeraj, Peerani, Farhad, Meserve, Joseph, Kochhar, Gursimran, Chaudrey, Khadija, Hartke, Justin, Chilukuri, Prianka, Koliani-Pace, Jenna, Winters, Adam, Katta, Leah, Shmidt, Eugenia, Hirten, Robert, Faleck, David, Parikh, Malav P., Whitehead, Diana, Boland, Brigid S., Singh, Siddharth, Sagi, Sashidhar Varma, Fischer, Monika, Chang, Shannon, Barocas, Morris, Luo, Michelle, Lasch, Karen, Bohm, Matthew, Lukin, Dana, Sultan, Keith, Swaminath, Arun, Hudesman, David, Gupta, Nitin, Shen, Bo, Kane, Sunanda, Loftus, Edward V., Siegel, Corey A., Sands, Bruce E., Colombel, Jean-Frederic, Sandborn, William J., Dulai, Parambir S.
Publicado 2019

Association of ultra-processed food intake with risk of inflammatory bowel disease: prospective cohort study

por Narula, Neeraj, Wong, Emily C L, Dehghan, Mahshid, Mente, Andrew, Rangarajan, Sumathy, Lanas, Fernando, Lopez-Jaramillo, Patricio, Rohatgi, Priyanka, Lakshmi, P V M, Varma, Ravi Prasad, Orlandini, Andres, Avezum, Alvaro, Wielgosz, Andreas, Poirier, Paul, Almadi, Majid A, Altuntas, Yuksel, Ng, Kien Keat, Chifamba, Jephat, Yeates, Karen, Puoane, Thandi, Khatib, Rasha, Yusuf, Rita, Boström, Kristina Bengtsson, Zatonska, Katarzyna, Iqbal, Romaina, Weida, Liu, Yibing, Zhu, Sidong, Li, Dans, Antonio, Yusufali, Afzalhussein, Mohammadifard, Noushin, Marshall, John K, Moayyedi, Paul, Reinisch, Walter, Yusuf, Salim
Publicado 2021